SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001607062-15-000310
Filing Date
2015-07-14
Accepted
2015-07-14 11:10:40
Documents
5
Effectiveness Date
2015-07-14

Document Format Files

Seq Description Document Type Size
1 DEFA14A gnbt71415defa14a.htm DEFR14A 17406
2 GRAPHIC image_001.gif GRAPHIC 13309
3 GRAPHIC image_002.gif GRAPHIC 28862
4 GRAPHIC image_003.gif GRAPHIC 5126
5 GRAPHIC image_004.gif GRAPHIC 26985
  Complete submission text file 0001607062-15-000310.txt   121344
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEFR14A | Act: 34 | File No.: 000-25169 | Film No.: 15986788
SIC: 2834 Pharmaceutical Preparations